glp 1 colitis SAFETY AND CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL DISEASE PATIENTS GLP-1 receptor agonists (GLP-1 RAs)

It does not predict how Hers, Fridays, or any compound will perform, but it lets you enter the decision with context rather than guesswork

Experience with intraplaque injection of verapamil for Peyronies disease

Medicare Data (2025): Once-weekly GLP-1 RAs (especially semaglutide) showed superior MACE reduction compared to SGLT2 inhibitors in Medicare beneficiaries with atherosclerotic cardiovascular disease (ASCVD)

12 , 18 , 19 , 20 While there continues to be a robust area of research into drug treatment for MASLD, currently there is only 1 (recently) approved pharmacological therapy, resmetirom, a THR agonist

Those who experience adverse reactions to bremelanotide can reduce the dosage